Here are relevant reports on : clinical-trials-market
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
U.S. Healthcare BPO Market - Payer (Claims Processing, HR Services, and Finance and Accounts), Provider (Medical Billing and Coding), and Pharmaceutical (Clinical Trials, Contract Manufacturing, and Non-Clinical Services) - Trends and Global Forecasts to 2018
The U.S. healthcare outsourcing market has great potential for growth owing to the measures taken by the government to curb the ever-increasing healthcare costs. The other factors that have led to the growth of the market are: developments and innovation in information technology and regulatory changes. Approximately 75% of U.S. healthcare companies outsource their work to external locations. This is due to the shortage of qualified staff in key positions, such as nurses and coders, and due to the new set of rules and regulations that they need to comply with. Some services that are commonly outsourced are insurance claims processing, adjudication and receivables management, billing and coding services, radiology reporting, transcription services, and clinical outsourcing, among others.
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Clinical Information systems (CIS) Market (2011-2016)
Clinical information systems include software solutions that enable efficient clinical workflow. Clinical systems include EMR, computerized physician order entry, laboratory information systems, pharmacy information systems, radiology information systems, and PACS. The clinical information systems market in developed countries is growing with higher CAGR, however emerging markets are currently very nascent. Presently, clinical information systems dominate the HIS market due to their high price and rising adoption. Budgetary constraints due to low awareness levels are however restraining market growth. The global clinical information systems market is expected to grow from $1.2 billion in 2009 to $2.8 billion in 2015, at an estimated CAGR of 14.8% from 2010 to 2015.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Non Clinical Information Systems Market (2011-2016)
Non-clinical healthcare systems (NCHS) facilitate revenue cycle management and also offer automatic patient billing, cost accounting, payroll, and claims management. These functions gain high significance in light of the reported fact that improper revenue cycle management in hospitals causes a 3% to 5% loss of net revenue. For a 250-bed hospital, this figure means an annual loss of $3.5 million to $7.5 million. Improved r e lat ion with payors and patients are improved revenue cycle management are driving this market. The administrative/non-clinical systems market revenue was $12.5 billion globally in 2010. The Non Clinical Information Systems Market is estimated to reach $20.9 billion in 2015 growing at a CAGR of 10.8%.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016)
Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Packaging Market - Global Forecast to 2024
This study will involve the extensive use of both primary and secondary sources. The research process will involve the study of various factors affecting the industry, to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
AI in Clinical Care Market - Global Forecast 2024 to 2030
Intel Corporation (US), Siemens Healthcare GmbH (Germany), NVIDIA Corporation (US), Medtronic (Ireland), Amazon Web Services, Inc. (US), GE Healthcare (US), Metadvice Ltd. (UK), PathAI (US), Babylon Health (UK), AiCure (US), and Arterys (US) are few key players in the AI in clinical care market globally.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
At-Home Blood Collection Devices Market by Product (Lancets, DBS Kits), Sample Type (Liquid, Dried), Collection Method (Push-button, Laser), Device Type (Self, Professional), Application (Diagnostics, Screening, Clinical Trials) - Global Forecast to 2029
The global At-home blood collection devices market, valued at US$89.4 million in 2023, stood at US$93.5 million in 2024 and is projected to advance at a resilient CAGR of 7.6% from 2024 to 2029, culminating in a forecasted valuation of US$135.0 million by the end of the period. Several factors drive the At-home blood collection devices market. Improvement in device technology is making them less invasive, user-friendly, and less painful to the consumer; for example, bladeless or needle-free sampling.
- Published: February 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
